New research suggests that our universe has no dark matter
Science Daily: Pharmacology News
MARCH 15, 2024
A new study challenges the current model of the universe by showing that, in fact, it has no room for dark matter.
Fri.Mar 15, 2024
342 
Madrigal, FDA approval in hand, outlines plan to sell MASH drug
BioPharma Drive: Drug Pricing
MARCH 15, 2024
The company expects initial uptake of Rezdiffra, which costs $47,400 per year, to be slow as doctors and insurers establish the protocols needed to find patients eligible for treatment.
Join 15,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recap of CDD User Group Meeting – Berlin 2024
Collaborative Drug
MARCH 15, 2024
CDD User Group Meeting in Berlin. Contributions from experts at Bayer Co.Lab, PROTEROS biostructures GmbH, Refoxy Pharma, PROSION Therapeutics, Schrödinger.
Waterborne Parasite That Can Kill Dogs Is Spreading to U.S. West
Drugs.com
MARCH 15, 2024
FRIDAY, March 15, 2024 -- A parasite that can kill dogs has been found in a portion of the Colorado River that runs through Southern California.Heterobilharzia americana is a flatworm usually referred as liver fluke. It has never been reported.
Bridging Innovation & Patient Care: The Growing Role of AI
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Drug Discovery Industry Roundup with Barry Bunin — March 15, 2024
Collaborative Drug
MARCH 15, 2024
“Long Covid ‘Brain Fog’ May Be Due to Leaky Blood-Brain Barrier Ozempic Taking off in China? Is Exercise More Effective For Women than Men?
Signup to get articles personalized to your interests!
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
More Trending
Bristol Myers cell therapy wins first-of-its-kind approval
BioPharma Drive: Drug Pricing
MARCH 15, 2024
Sold as Breyanzi, the therapy is now cleared for use in certain adults with hard-to-treat forms of relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.
Step Away From the 'Go Barefoot Everywhere' TikTok Trend, Experts Say
Drugs.com
MARCH 15, 2024
FRIDAY, March 15, 2024 -- Attention, America: ignore the "experts" on TikTok and put your shoes on.Barefootin' is risky business, according to Dr. Sari Priesand, a foot specialist at Michigan Medicine-University of Michigan in Ann Arbor."Keep the.
The Four Key Factors to Evaluate When Insourcing vs. Outsourcing Patient Support Programs
Drug Channels
MARCH 15, 2024
Today’s guest post comes from Josh Marsh, Vice President and General Manager of Sonexus™ Access and Patient Support at Cardinal Health. Josh discusses factors that drive manufacturers to insource versus outsource patient support services. He shares data from a Cardinal Health survey of biopharmaceutical companies and offers four factors to consider when evaluating your patient support program.
'Space Headaches' Can Hit Astronauts, Study Finds
Drugs.com
MARCH 15, 2024
FRIDAY, March 15, 2024 -- Astronauts who have never had headaches may develop migraines and other tension-type headaches for the first time when they go into space.A side effect of zero gravity, these headaches start with motion sickness as.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Shaping the Future: Eli Lilly's Role in the Weight Management Revolution
DrugBank
MARCH 15, 2024
The weight loss industry has emerged as a major hub for innovative research, groundbreaking treatments, and economic opportunity. According to Grand View Research , the global weight loss and weight management market size was valued at $142.5 billion in 2022 and is projected to grow at a compound annual growth rate of 9.94% from 2023 to 2030. Many drug discovery and repurposing initiatives are shifting focus to capturing a share of this market in light of Eli Lilly and the Novo Nordisk success.
FDA Approves First Drug for Common, Serious Liver Disease
Drugs.com
MARCH 15, 2024
FRIDAY, March 15, 2024 -- Millions of Americans whose livers develop scar tissue due to a common disease now have the first approved drug, Rezdiffra, to treat the condition, the U.S. Food and Drug Administration announced Thursday.The condition is.
New insights could improve treatment of liver fibrosis
SCIENMAG: Medicine & Health
MARCH 15, 2024
The liver is not only the largest internal organ but also vital for human life as a metabolic center. It also possesses remarkable self-healing powers: even when large portions are removed, such as during surgery, they quickly regenerate in healthy individuals.
Eating Healthy Slows 'Aging Clock,' Helping to Shield Your Brain From Dementia
Drugs.com
MARCH 15, 2024
FRIDAY, March 15, 2024 -- Scientists have long noticed that folks who eat healthy have healthier brains as they age, including lowered odds for dementia.Now, researchers believe they know why: Regimens like the heart-healthy Mediterranean or DASH.
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Longitudinal gut fungal alterations and potential fungal biomarkers for the progression of primary liver disease
SCIENMAG: Medicine & Health
MARCH 15, 2024
Science China Life Sciences recently reported on the research results of Lanjuan Li’s team from Zhejiang university. Recent advances in microbiome research have revealed complex changes in gut microecology across various disease states, highlighting their profound impact on disease progression.
Living in Poor Neighborhoods Ups Risks for Dementia, Early Aging
Drugs.com
MARCH 15, 2024
FRIDAY, March 15, 2024 -- Doctors looking to help their patients head off dementia may want to ask for their address.An international team of researchers has linked accelerated brain aging and a higher risk of thinking declines to living in a.
Newly discovered receptor influences gut development in fruit flies
SCIENMAG: Medicine & Health
MARCH 15, 2024
Adhesion GPCRs belong to the large family of G protein-coupled receptors (GPCRs). There are about 700 variants in humans, which are responsible for sensory impressions, hormonal cycles, controlling the cardiovascular system and more. GPCRs translate stimuli that hit a cell from outside into an intracellular biochemical signal. Credit: Photo: Dr.
FDA Approves First Drug for Common, Serious Liver Disease, Rezdiffra
Drugs.com
MARCH 15, 2024
FRIDAY, March 15, 2024 -- Millions of Americans whose livers develop scar tissue due to a common disease now have the first approved drug, Rezdiffra, to treat the condition, the U.S. Food and Drug Administration announced Thursday. The condition is.
Deliver Fast, Flexible Clinical Trial Insights with Spotfire
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
New tentative approval for Sandoz Inc drug rifaximin
Drug Patent Watch
MARCH 15, 2024
Rifaximin is the generic ingredient in one branded drug marketed by Salix Pharms and is included in one NDA. There are twenty-nine patents protecting this compound.
MRI May Predict Who'll Respond Best to Schizophrenia Treatment
Drugs.com
MARCH 15, 2024
FRIDAY, March 15, 2024 -- Specialized brain scans may accurately predict whether a psychotic patient will go on to develop treatment-resistant schizophrenia, Dutch researchers report.The scan — called a neuromelanin-sensitive MRI, or NM-MRI for.
New tentative approval for Zydus Pharms drug empagliflozin;linagliptin;metformin hydrochloride
Drug Patent Watch
MARCH 15, 2024
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.
FDA revises early Alzheimer’s draft guidance, adds considerations for surrogate endpoints
Agency IQ
MARCH 15, 2024
BY AMANDA CONTI Given the progressive nature of Alzheimer’s disease (AD), developing treatments for early-stage populations is crucial. FDA has now issued a second revision to its draft guidance on developing drugs for this population. The guidance walks through appropriate outcomes—including surrogate endpoints—but emphasizes the importance of getting agency input.
Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Which pharmaceutical companies have the most drug patents in Peru?
Drug Patent Watch
MARCH 15, 2024
This chart shows the pharmaceutical companies with the most patents in Peru.
California publishes draft regulations for landmark plastic pollution reduction act
Agency IQ
MARCH 15, 2024
BY WALKER LIVINGSTON, ESQ CalRecycle has launched the formal rulemaking process for Senate Bill 54, which will implement a sweeping plan to reduce plastic waste in the state by 2032. The newly released draft regulations, statement of reason and regulatory impact assessment all point to the wide-reaching implications that the rule will have for a variety of industries across the state.
New patent for Azurity drug KONVOMEP
Drug Patent Watch
MARCH 15, 2024
Annual Drug Patent Expirations for KONVOMEP Konvomep is a drug marketed by Azurity and is included in one NDA. It is available from one supplier.
FDA drafts ‘select updates’ to guidance on medical device cybersecurity, addressing statutory requirements
Agency IQ
MARCH 15, 2024
BY LAURA DIANGELO, MPH In late 2023, the FDA finalized a long-awaited guidance on medical device cybersecurity – but also promised updates to that final guidance which would address certain statutory requirements. Today, the agency published a draft version of those “select updates,” which delineate how the FDA will interpret key statutory definitions and provide expectations for documentation and for bringing existing devices into compliance.
New patent for Axsome drug AUVELITY
Drug Patent Watch
MARCH 15, 2024
Annual Drug Patent Expirations for AUVELITY Auvelity is a drug marketed by Axsome and is included in one NDA. It is available from one supplier.
CORE-MD research showcases possibilities of patient-reported outcomes in high-risk device clinical investigations
Agency IQ
MARCH 15, 2024
BY COREY JASEPH, MS, RAC The latest webinar from the CORE-MD consortium presented the group’s research into how patient-reported outcome measures have been used in clinical evaluations of high-risk medical devices. Researchers reported their findings from systematic literature reviews and a Delphi study of the use of different patient-reported outcome measures – and how patients thought these tools could be made better.
New patent for Springworks drug OGSIVEO
Drug Patent Watch
MARCH 15, 2024
Annual Drug Patent Expirations for OGSIVEO Ogsiveo is a drug marketed by Springworks and is included in one NDA. It is available from one supplier.
ECHA unveils 6-month plan to evaluate universal PFAS restriction proposal
Agency IQ
MARCH 15, 2024
BY SCOTT STEPHENS, MPA ECHA announced the steps it will take over the next six months to evaluate the proposed universal restriction on “forever chemicals.” The unprecedented volume of comments received during last year’s public consultation means EU regulators have had to resort to exceptional measures in the REACH restriction procedure as they seek to maintain transparency, objectivity and a high level of quality.
Let's personalize your content